# Role of Vitamin C to Augment Iron Chelation With DFP or DFX

> **NCT02083575** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 50 (estimated)

## Conditions studied

- Vitamin c
- Thalassemia Major
- Iron Chelation

## Interventions

- **DRUG:** Vitamin C, Defriprone, deferisarox
- **DRUG:** deferiprone , deferesarox

## Key facts

- **NCT ID:** NCT02083575
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2014-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02083575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02083575, "Role of Vitamin C to Augment Iron Chelation With DFP or DFX". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT02083575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*